The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma
2024 · Signal Transduction and Targeted Therapy · 41 citations
https://doi.org/10.1038/s41392-024-01963-5
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
407
Citations
10
h-index
11
i10-index
Jiong-Jie Yu is an academic researcher from Zhejiang University. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease Diagnosis and Treatment & Cancer, Lipids, and Metabolism. The author has an h-index of 10, co-authored 37 publications.
Click to start Chat